145 related articles for article (PubMed ID: 3117445)
1. Ovulation of a single dominant follicle during treatment with low-dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome.
Polson DW; Mason HD; Saldahna MB; Franks S
Clin Endocrinol (Oxf); 1987 Feb; 26(2):205-12. PubMed ID: 3117445
[TBL] [Abstract][Full Text] [Related]
2. Ovulation induction with low doses of "pure" follicle stimulating hormone using a fixed protocol in patients with polycystic ovarian disease.
Bregieiro LO; de Moura MD; Ferriani RA; Bailão LA; de Sá MF
Int J Fertil Menopausal Stud; 1993; 38(3):152-9. PubMed ID: 8348163
[TBL] [Abstract][Full Text] [Related]
3. Treatment of polycystic ovary disease with chronic low-dose follicle stimulating hormone: biochemical changes and ultrasound correlation.
Seibel MM; Kamrava MM; McArdle C; Taymor ML
Int J Fertil; 1984; 29(1):39-43. PubMed ID: 6146583
[TBL] [Abstract][Full Text] [Related]
4. Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome.
Hamilton-Fairley D; Kiddy D; Watson H; Sagle M; Franks S
Hum Reprod; 1991 Sep; 6(8):1095-9. PubMed ID: 1806568
[TBL] [Abstract][Full Text] [Related]
5. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation.
Anderson RA; Groome NP; Baird DT
Clin Endocrinol (Oxf); 1998 May; 48(5):577-84. PubMed ID: 9666869
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled study comparing the endocrine effects of pulsatile intravenous gonadotropin-releasing hormone after gonadotropin-releasing hormone agonist pretreatment versus clomiphene citrate in patients with polycystic ovary syndrome.
Timmerman-van Kessel EC; Cikot RJ; Dargel-Donkers EJ; Zwertbroek W; van Dop PA; Schoot DC
Fertil Steril; 2000 Jun; 73(6):1145-8. PubMed ID: 10856472
[TBL] [Abstract][Full Text] [Related]
7. Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations.
Zaidi J; Jacobs H; Campbell S; Tan SL
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):188-96. PubMed ID: 9793191
[TBL] [Abstract][Full Text] [Related]
8. The step-down principle in gonadotrophin treatment and the role of GnRH analogues.
Fauser BC; Donderwinkel P; Schoot DC
Baillieres Clin Obstet Gynaecol; 1993 Jun; 7(2):309-30. PubMed ID: 8358893
[TBL] [Abstract][Full Text] [Related]
9. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
[TBL] [Abstract][Full Text] [Related]
10. Follicle stimulating hormone (FSH) dynamics of low dose step-up ovulation induction with FSH in patients with polycystic ovary syndrome.
van der Meer M; Hompes PG; Scheele F; Schoute E; Veersema S; Schoemaker J
Hum Reprod; 1994 Sep; 9(9):1612-7. PubMed ID: 7836509
[TBL] [Abstract][Full Text] [Related]
11. The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome.
Dale PO; Tanbo T; Haug E; Abyholm T
Hum Reprod; 1998 Mar; 13(3):567-70. PubMed ID: 9572412
[TBL] [Abstract][Full Text] [Related]
12. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G
J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
[TBL] [Abstract][Full Text] [Related]
13. Sequential step-up and step-down dose regimen: an alternative method for ovulation induction with follicle-stimulating hormone in polycystic ovarian syndrome.
Hugues JN; Cédrin-Durnerin I; Avril C; Bulwa S; Hervé F; Uzan M
Hum Reprod; 1996 Dec; 11(12):2581-4. PubMed ID: 9021354
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of follicular growth with "pure" FSH in patients with anovulation and elevated LH levels.
Schoemaker J; Wentz AC; Jones GS; Dubin NH; Sapp KC
Obstet Gynecol; 1978 Mar; 51(3):270-7. PubMed ID: 628528
[TBL] [Abstract][Full Text] [Related]
15. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
[TBL] [Abstract][Full Text] [Related]
16. Serum follicle-stimulating and luteinizing hormone and progesterone in single and multiple gestations following induction of ovulation.
Fogel M; Rubin BL; Ossowski R
Am J Obstet Gynecol; 1972 Mar; 112(5):629-39. PubMed ID: 5059593
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
[TBL] [Abstract][Full Text] [Related]
19. Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: the difference between responders and nonresponders.
Polson DW; Kiddy DS; Mason HD; Franks S
Fertil Steril; 1989 Jan; 51(1):30-4. PubMed ID: 2491994
[TBL] [Abstract][Full Text] [Related]
20. Bromocriptine treatment of women with clomiphene-resistant polycystic ovary syndrome.
Polson DW; Mason HD; Franks S
Clin Endocrinol (Oxf); 1987 Feb; 26(2):197-203. PubMed ID: 3117444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
